These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 2111349)
1. Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-alpha and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody. Eisenthal A; Cameron RB; Rosenberg SA J Immunol; 1990 Jun; 144(11):4463-71. PubMed ID: 2111349 [TBL] [Abstract][Full Text] [Related]
2. The effect of various cytokines on the in vitro induction of antibody-dependent cellular cytotoxicity in murine cells. Enhancement of IL-2-induced antibody-dependent cellular cytotoxicity activity by IL-1 and tumor necrosis factor-alpha. Eisenthal A; Rosenberg SA J Immunol; 1989 Apr; 142(7):2307-13. PubMed ID: 2647849 [TBL] [Abstract][Full Text] [Related]
3. Effect of combined therapy with lymphokine-activated killer cells, interleukin 2 and specific monoclonal antibody on established B16 melanoma lung metastases. Eisenthal A; Cameron RB; Uppenkamp I; Rosenberg SA Cancer Res; 1988 Dec; 48(24 Pt 1):7140-5. PubMed ID: 3263900 [TBL] [Abstract][Full Text] [Related]
4. Combinations of the cytokines IL-12, IL-2 and IFN-alpha significantly augment whereas the cytokine IL-4 suppresses the cytokine-induced antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2. Flieger D; Spengler U; Beier I; Sauerbruch T; Schmidt-Wolf I Cytokine; 2000 Jun; 12(6):756-61. PubMed ID: 10843759 [TBL] [Abstract][Full Text] [Related]
5. Systemic induction of cells mediating antibody-dependent cellular cytotoxicity following administration of interleukin 2. Eisenthal A; Rosenberg SA Cancer Res; 1989 Dec; 49(24 Pt 1):6953-9. PubMed ID: 2573425 [TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo. Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482 [TBL] [Abstract][Full Text] [Related]
7. Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A. Flieger D; Spengler U; Beier I; Sauerbruch T; Schmidt-Wolf IG Z Gastroenterol; 2000 Aug; 38(8):615-22. PubMed ID: 11031784 [TBL] [Abstract][Full Text] [Related]
8. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity. Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715 [TBL] [Abstract][Full Text] [Related]
9. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model. Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050 [TBL] [Abstract][Full Text] [Related]
11. In vivo administration of interferon alpha and interleukin 2 induces proliferation of lymphoid cells in the organs of mice. Puri RK; Travis WD; Rosenberg SA Cancer Res; 1990 Sep; 50(17):5543-50. PubMed ID: 2386960 [TBL] [Abstract][Full Text] [Related]
12. Effect of anti-B16 melanoma monoclonal antibody on established murine B16 melanoma liver metastases. Eisenthal A; Lafreniere R; Lefor AT; Rosenberg SA Cancer Res; 1987 Jun; 47(11):2771-6. PubMed ID: 3494504 [TBL] [Abstract][Full Text] [Related]
13. Effect of recombinant human tumor necrosis factor alpha on the induction of antibody-dependent cellular cytotoxicity in the treatment of established B16 melanoma liver nodules. Eisenthal A; McIntosh JK Cancer Immunol Immunother; 1990; 31(4):243-9. PubMed ID: 2379220 [TBL] [Abstract][Full Text] [Related]
14. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198 [TBL] [Abstract][Full Text] [Related]
15. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy. Pak AS; Ip G; Wright MA; Young MR Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804 [TBL] [Abstract][Full Text] [Related]
16. Treatment of a murine B cell lymphoma with monoclonal antibodies and IL 2. Berinstein N; Levy R J Immunol; 1987 Aug; 139(3):971-6. PubMed ID: 3496394 [TBL] [Abstract][Full Text] [Related]
17. Interactive effects of alpha-interferon A/D and interleukin 2 on murine lymphokine-activated killer activity: analysis at the effector and precursor level. Chikkala NF; Lewis I; Ulchaker J; Stanley J; Tubbs R; Finke JH Cancer Res; 1990 Feb; 50(4):1176-82. PubMed ID: 2297766 [TBL] [Abstract][Full Text] [Related]
18. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells. Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412 [TBL] [Abstract][Full Text] [Related]
19. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo. Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990 [TBL] [Abstract][Full Text] [Related]
20. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease. Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]